UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation
Journal of Virology · 2025
DOI: 10.1128/jvi.00741-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Yongjun Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of System Biology of Pathogens, Christophe Mérieux Laboratory National Institute of Pathogen Biology, Chinese Academy of Medical S…. Hauptthemen laut MEDLINE: SARS-CoV-2, Cathepsin L, Virus Internalization, Antiviral Agents. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Since the outbreak of SARS-CoV-2, viral mutations have posed significant challenges in identifying therapeutic targets and developing broad-spectrum antiviral drugs. Post-translational modifications of genes involved in interferon production and signaling pathways play a crucial role in regulating interferon responses. In this study, we employed CRISPR-Cas9 screening based on adenine base editors to investigate functional amino acids in 1,278 innate immune-related genes. This approach, which converts A-T base pairs into G-C base pairs to probe the functional importance of specific amino acids, allowed us to identify 17 vital factors involved in SARS-CoV-2 infection. Among the candidate genes, genetic knockdown of EHMT2 exhibited the strongest antiviral effect. Further analysis revealed that UNC0638, a selective inhibitor of EHMT2, significantly reduced the endosomal entry of SARS-CoV-2 in pseudovirus assays. The observed inhibitory effect was consistently observed across multiple SARS-CoV-2 variants, including Alpha, Beta, Delta, and Omicron. Mechanistically, UNC0638 reduced mature cathepsin L (CTSL) levels, impairing the proteolytic cleavage of SARS-CoV-2 spike protein and subsequent membrane fusion, a critical step for viral entry. Our findings uncover EHMT2 as a host dependency factor and reveal the antiviral mechanism of EHMT2 inhibitors through CTSL maturation blockade. These results advance the understanding of host factors in SARS-CoV-2 infection and provide a strategic framework for developing host-targeted antiviral therapies. IMPORTANCE In this study, we demonstrated that knockdown or knockout of EHMT2 inhibited SARS-CoV-2 infection, and inhibitors of EHMT2, including UNC0638, UNC0642, and BIX01294 showed similar restrictive effects. Mechanistically, the EHMT2 inhibitor UNC0638 restricts spike-mediated cell entry by inhibiting the maturation of CTSL, a critical protease required for SARS-CoV-2 entry via the endosomal pathway. Importantly, CTSL is not only essential for SARS-CoV-2 but also plays a key role in the entry of other coronaviruses that utilize similar pathways. Therefore, EHMT2 inhibitors could have broader applications as pan-coronavirus therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of System Biology of Pathogens, Christophe Mérieux Laboratory National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College) Ministry of Education, Beijing, China.
- State Key Laboratory of Common Mechanism Research for Major Diseases, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, China.
- Biomedical Pioneering Innovation Center, Peking-Tsinghua Center for Life Sciences, Peking University Genome Editing Research Center, State Key Laboratory of Gene Function and Modulation Research, School of Life Sciences…
ORCID-Profile: Lili Ren, Wensheng Wei, Xiaobo Lei, Jianwei Wang
Zitieren
APA
Chen, Y., Shi, Y., Zuo, X., Dong, X., Xiao, X., Chen, L., Xiang, Z., Ren, L., Zhou, Z., Wei, W., Lei, X., & Wang, J. (2025). UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation. Journal of Virology. https://doi.org/10.1128/jvi.00741-25
Vancouver
Chen Y, Shi Y, Zuo X, Dong X, Xiao X, Chen L, et al. UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation. Journal of Virology. 2025. doi:10.1128/jvi.00741-25
BibTeX
@article{Chen2025,
author = {Chen, Yongjun and Shi, Yujin and Zuo, Xiaoyan and Dong, Xiaojing and Xiao, Xia and Chen, Lan and Xiang, Zichun and Ren, Lili and Zhou, Zhuo and Wei, Wensheng and Lei, Xiaobo and Wang, Jianwei},
title = {UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.00741-25}
}
EUVIMED